dakshadmin

PCD Pharma Franchise Opportunities in Jharkhand with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Jharkhand with Daksh Diabetes and Cardiac Care Recent data from the Indian Council of Medical Research (ICMR) reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Jharkhand, affecting both rural and tribal populations. The ICMR-INDIAB study found that the prevalence of diabetes in Jharkhand is 6.32%, with a significant urban-rural divide—13% in urban areas compared to just 3% in rural areas. A 2022-2023 community-based study in rural Jharkhand found an even higher diabetes prevalence of 16.3%. The burden of hypertension is equally alarming. NFHS-5 data shows that 17.8% of women and 22.6% of men aged 15 and above have hypertension. A 2023 hospital-based study in Jharkhand found that 33.4% of patients visiting a cardiac OPD had hypertension, with 40.1% demonstrating inadequate knowledge about the condition. A 2026 study among the primitive Sabar tribe in East Singhbhum found a hypertension prevalence of 19.9%. Among older adults in Deoghar district, 42.3% were hypertensive and 19.9% were diabetic. Tribal communities, traditionally considered low-risk, are now experiencing rising rates due to lifestyle shifts, with 19.9% of the Sabar tribe hypertensive and 38.4% overweight or obese. A 2024-25 Jharkhand-based study found metabolic syndrome prevalence at 10%, with men nearly twice as likely to be obese compared to women. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Jharkhand families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Jharkhand 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Jharkhand patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Jharkhand Daksh works with hospitals, clinics, and pharmacies across Jharkhand to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and growing pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Jharkhand PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Ranchi Cardiac diabetic PCD company in Ranchi PCD pharma franchise in Jamshedpur Cardiac diabetic products in Jamshedpur PCD pharma franchise in Dhanbad Diabetic cardiac PCD franchise in Dhanbad PCD pharma franchise in Bokaro Cardiac diabetic PCD company in Bokaro PCD pharma franchise in Hazaribagh Cardiac diabetic products in Hazaribagh PCD pharma franchise in Deoghar Diabetic cardiac PCD franchise in Deoghar PCD pharma franchise in Giridih Cardiac diabetic PCD company in Giridih PCD pharma franchise in Dumka Cardiac diabetic products in Dumka PCD pharma franchise in Palamu Diabetic cardiac PCD franchise in Palamu PCD pharma franchise in Simdega Cardiac diabetic PCD company in Simdega Conclusion The diabetes and heart disease epidemic in Jharkhand is not just a statistic—it is a reality affecting thousands of families. With a diabetes prevalence of 6.32%, hypertension affecting 33.4% of OPD patients, and tribal populations showing rates as high as 19.9%, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Jharkhand with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Himachal Pradesh with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Himachal Pradesh with Daksh Diabetes and Cardiac Care Recent data reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Himachal Pradesh. According to the Longitudinal Ageing Study in India (LASI 2017-18), 11.4% of men and 12.2% of women aged 45 and above have diabetes. The National Family Health Survey (NFHS-5) found that the diabetes prevalence in Himachal Pradesh is higher than the national average, with rates significantly elevated in urban areas. The burden of hypertension is equally alarming. An ICMR study found that 16.7% of the population in Himachal Pradesh has raised blood pressure, with 35.3% in the pre-hypertension stage. This indicates a massive at-risk population that is on the verge of developing full-blown hypertension. The primary drivers include the traditional Himachali diet—rich in high glycemic index foods like rice and wheat, high saturated fat from ghee and butter, and sugar-rich sweets—combined with sedentary occupations, stressful urban living in cities like Shimla, Solan, and Mandi, declining physical activity, and increased consumption of processed foods. A recent national survey found that 69% of households in Punjab, Haryana, and Himachal have members addicted to sugar or sugary products, making it the single biggest contributor to the diabetes epidemic. Additionally, fatty liver cases in Himachal Pradesh have increased by 40% in the last six months, with doctors attributing this to junk food and spicy food consumption, affecting even 10-year-old children. The state also has a high prevalence of hidden diabetes, with many cases going undiagnosed. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Himachal families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Himachal Pradesh 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Himachal patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Himachal Pradesh Daksh works with hospitals, clinics, and pharmacies across Himachal Pradesh to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The pharma market in Himachal offers low investment (starting at ₹25,000) with high profit margins and monopoly rights in selected areas. Popular Locations for PCD Pharma Franchise in Himachal Pradesh PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Baddi Cardiac diabetic PCD company in Baddi PCD pharma franchise in Solan Cardiac diabetic products in Solan PCD pharma franchise in Paonta Sahib Diabetic cardiac PCD franchise in Paonta Sahib PCD pharma franchise in Shimla Cardiac diabetic PCD company in Shimla PCD pharma franchise in Mandi Cardiac diabetic products in Mandi PCD pharma franchise in Kangra Diabetic cardiac PCD franchise in Kangra PCD pharma franchise in Una Cardiac diabetic PCD company in Una PCD pharma franchise in Hamirpur Cardiac diabetic products in Hamirpur PCD pharma franchise in Kullu Diabetic cardiac PCD franchise in Kullu PCD pharma franchise in Chamba Cardiac diabetic PCD company in Chamba Conclusion The diabetes and heart disease epidemic in Himachal Pradesh is not just a statistic—it is a reality affecting thousands of families. With the state recording a diabetes prevalence of 11.4% among men and 12.2% among women aged 45+ , pre-hypertension affecting 35.3% , and 40% increase in fatty liver cases, the burden is already immense and growing . But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Himachal Pradesh with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Haryana with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Haryana with Daksh Diabetes and Cardiac Care Recent data from the Ministry of Health and Family Welfare’s National Family Health Survey-6 (2023-24) reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Haryana. The survey shows that high or very high blood sugar affects 16.7% of women and 18.5% of men, up significantly from 11.9% and 13.5% respectively in NFHS-5. Urban men record 19.8% and rural men 17.7%, indicating the gap between city and village is narrowing rapidly. Even more concerning, 33.2% of women and 33.9% of men in Haryana are now overweight or obese, rising to 44.0% among urban women – both figures substantially higher than NFHS-5. A community-based study in rural Haryana found that overweight and obesity were the strongest risk factors for diabetes, with nearly a sixfold increase in odds (OR: 5.80). The prevalence of newly detected diabetes in this rural population was 6.2%, with adults aged 50-59 years being at 3.4 times higher risk. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Haryana families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Haryana 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Haryana patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Haryana Daksh works with hospitals, clinics, and pharmacies across Haryana to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and strategic location—Haryana is actively transforming into a globally competitive healthcare manufacturing hub through its Pharmaceutical and Medical Devices Manufacturing Policy 2026, targeting over ₹10,000 crore in investments and 20,000 new jobs—there is immense potential to build a meaningful healthcare business while serving your community. Popular Locations for PCD Pharma Franchise in Haryana PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Panchkula Cardiac diabetic PCD company in Panchkula PCD pharma franchise in Chandigarh Cardiac diabetic PCD company in Chandigarh PCD pharma franchise in Gurugram Cardiac diabetic products in Gurugram PCD pharma franchise in Faridabad Diabetic cardiac PCD franchise in Faridabad PCD pharma company in Ambala Cardiac diabetic PCD franchise in Ambala PCD franchise in Hisar Cardiac diabetic products in Hisar PCD pharma franchise in Karnal Diabetic cardiac PCD company in Karnal PCD pharma franchise in Kurukshetra Cardiac diabetic PCD franchise in Kurukshetra PCD franchise company in Rohtak Cardiac diabetic medicines in Rohtak PCD pharma in Yamunanagar Diabetic cardiac care in Yamunanagar Conclusion The diabetes and heart disease epidemic in Haryana is not just a statistic – it is a reality affecting millions of families. Many individuals are silently struggling with these conditions, often unaware of their impact on long-term health. But there is hope. With the right medications, proper awareness, and accessible healthcare, diabetic and cardiac patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution – providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Haryana with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Gujarat with Daksh Diabetes and Cardiac Care

Uncategorized /

PCD Pharma Franchise Opportunities in Gujarat with Daksh Diabetes and Cardiac Care Recent data from the National Family Health Survey (NFHS-6) for 2023-24 reveals that lifestyle diseases, particularly diabetes and hypertension, are rising at an alarming pace across Gujarat. The state now records 18.6% of men and 16.4% of women with high blood sugar levels, while hypertension affects 22.3% of men and 20.9% of women. Perhaps most concerning, one in three Gujarati adults is now overweight or obese—women’s obesity jumped from 22.7% to 32.1% and men’s from 20.0% to 29.9% in just four years. According to the Global Burden of Disease study, diabetes prevalence in Gujarat increased at a rate of 0.67% per year between 1990 and 2021—from 157 to 262 individuals per 1 lakh population—placing the state among the top seven with the highest increase. The average age of diabetes diagnosis has dropped from the late 40s to the early 30s, making early-onset diabetes a growing crisis. The state has also seen a sharp rise in pre-diabetes, with 13.2% of the population in the pre-diabetic stage. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Gujarat families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Gujarat 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Gujarat patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Gujarat Daksh works with hospitals, clinics, and pharmacies across Gujarat to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The pharma market in Gujarat offers low investment with high profit margins and monopoly rights in selected areas. Popular Locations for PCD Pharma Franchise in Gujarat PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Ahmedabad Cardiac diabetic PCD company in Ahmedabad PCD pharma franchise in Surat Cardiac diabetic products in Surat PCD pharma franchise in Vadodara Diabetic cardiac PCD franchise in Vadodara PCD pharma franchise in Rajkot Cardiac diabetic PCD company in Rajkot PCD pharma franchise in Bhavnagar Cardiac diabetic products in Bhavnagar PCD pharma franchise in Jamnagar Diabetic cardiac PCD franchise in Jamnagar PCD pharma franchise in Junagadh Cardiac diabetic PCD company in Junagadh PCD pharma franchise in Gandhinagar Cardiac diabetic products in Gandhinagar PCD pharma franchise in Anand Diabetic cardiac PCD franchise in Anand PCD pharma franchise in Nadiad Cardiac diabetic PCD company in Nadiad Conclusion The diabetes and heart disease epidemic in Gujarat is not just a statistic—it is a reality affecting millions of families. With the state recording the highest edible oil consumption in India, obesity rates exceeding 32%, and early-onset diabetes dropping to the 30s, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution—providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Gujarat with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Goa with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Goa with Daksh Diabetes and Cardiac Care Recent data from the National Family Health Survey (NFHS-6) 2023-24 paints a stark picture of Goa’s deepening lifestyle disease crisis, with the state consistently outpacing national averages. The data reveals that 32.1% of men and 27.5% of women in Goa have blood sugar levels above 140mg/dl or are on diabetes medication far exceeding national averages of 20.9% for men and 17.8% for women. Goa’s 32.1% prevalence among men is the highest in the country, with the numbers rising sharply from 24.1% in NFHS-5. The obesity epidemic is equally alarming. Nearly half of Goa’s population is now overweight or obese, with 43.6% of men and 45.1% of women having a BMI of 25.0kg/m² or above compared to national averages of 27.3% for men and 30.7% for women. Goa also leads in abdominal obesity, with 51.8% affected. The rural-urban divide is striking, with urban men showing 36.3% diabetes prevalence compared to 27.4% in rural men, and urban women recording 48.3% obesity against 41.1% in rural areas. On hypertension, 27.5% of men and 26.2% of women have elevated blood pressure, with rural women recording higher rates at 27.8%. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Goa families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Goa 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Goa patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Goa Daksh works with hospitals, clinics, and pharmacies across Goa to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and booming pharmaceutical sector, there is immense potential to build a meaningful healthcare business while serving your community. The pharma market in Goa offers low investment (starting at ₹25,000) with high profit margins and monopoly rights in selected areas. Popular Locations for PCD Pharma Franchise in Goa PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Panaji Cardiac diabetic PCD company in Panaji PCD pharma franchise in Margao Cardiac diabetic products in Margao PCD pharma franchise in Vasco Diabetic cardiac PCD franchise in Vasco PCD pharma franchise in Mapusa Cardiac diabetic PCD company in Mapusa PCD pharma franchise in Ponda Cardiac diabetic products in Ponda PCD pharma franchise in Bicholim Diabetic cardiac PCD franchise in Bicholim PCD pharma franchise in Calangute Cardiac diabetic PCD company in Calangute PCD pharma franchise in Verna Cardiac diabetic products in Verna PCD pharma franchise in Curchorem Diabetic cardiac PCD franchise in Curchorem PCD pharma franchise in Canacona Cardiac diabetic PCD company in Canacona Conclusion The diabetes and heart disease epidemic in Goa is not just a statistic it is a reality affecting thousands of families. With the state recording the highest diabetes prevalence among men at 32.1% and obesity rates of over 43%, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Goa with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Chhattisgarh with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Chhattisgarh with Daksh Diabetes and Cardiac Care Recent data from the National Family Health Survey (NFHS-5) reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Chhattisgarh, with a prevalence of 9.9% for diabetes and 25.7% for hypertension. A 2025 study in an urban slum of Raipur found even higher rates 33% prevalence of hypertension and 16% prevalence of diabetes. Among the tribal population of Bastar district, the burden is particularly severe, with 47.3% hypertension prevalence and 34.9% pre-hypertension. The primary drivers include the traditional Chhattisgarhi diet rich in high glycemic index foods like rice, high saturated fat, and sugar-rich sweets combined with sedentary occupations, stressful urban living, declining physical activity, tobacco use, and alcohol consumption, all contributing to poor blood sugar regulation and awareness gaps in self-care practices . The pharmaceutical sector in Chhattisgarh is growing at a rate of 9.5%, with cities like Raipur, Bilaspur, Durg, and Bhilai emerging as key hubs for pharmaceutical distribution. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Chattisgarh families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Chhattisgarh 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Chhattisgarh patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Chhattisgarh Daksh works with hospitals, clinics, and pharmacies across Chhattisgarh to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With rising healthcare awareness and growing demand for quality medicines, the scope for PCD pharma franchise business in the state is rising, especially in rural areas where competition is low. Popular Locations for PCD Pharma Franchise in Chhattisgarh PCD Franchise PCD pharma franchise in Raipur Cardiac diabetic PCD company in Raipur PCD pharma franchise in Bilaspur Cardiac diabetic products in Bilaspur PCD pharma franchise in Durg Diabetic cardiac PCD franchise in Durg PCD pharma franchise in Bhilai Cardiac diabetic PCD company in Bhilai PCD pharma franchise in Korba Cardiac diabetic products in Korba PCD pharma franchise in Rajnandgaon Diabetic cardiac PCD franchise in Rajnandgaon PCD pharma franchise in Raigarh Cardiac diabetic PCD company in Raigarh PCD pharma franchise in Jagdalpur Cardiac diabetic products in Jagdalpur PCD pharma franchise in Ambikapur Diabetic cardiac PCD franchise in Ambikapur PCD pharma franchise in Dhamtari Cardiac diabetic PCD company in Dhamtari Conclusion The diabetes and heart disease epidemic in Chhattisgarh is not just a statistic – it is a reality affecting thousands of families. With a diabetes prevalence of 9.9% and hypertension prevalence of 25.7%, and tribal populations showing even higher rates, the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, patients can live long, healthy, and fulfilling lives.  Daksh Diabetic & Cardiac Care is committed to being part of this solution – providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Chhattisgarh with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Bihar with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Bihar with Daksh Diabetes and Cardiac Care Recent data from the Indian Council of Medical Research (ICMR) reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Bihar. The prevalence of diabetes in Bihar stands at 4.3%, while hypertension affects a staggering 17.15% of individuals aged 15 years and above. A 2025 population-based study in rural Patna district found a hypertension prevalence of 24.55%, with over 25% of the rural population already in the pre-hypertension stage. The tribal population is also increasingly affected—a study among the Tharu tribe found a hypertension prevalence of 32.5% and a diabetes prevalence of 4.8%. The primary drivers include the traditional Bihar diet—rich in high glycemic index foods like rice, high saturated fat from cooking oils, and sugar-rich sweets—combined with sedentary occupations, stressful urban living, declining physical activity, tobacco use, and alcohol consumption, all contributing to poor blood sugar regulation and awareness gaps in self-care practices . Studies have found that tobacco chewing, obesity, and high salt consumption are significantly associated with hypertension in rural Bihar. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Bihar families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Bihar 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Bihar patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Bihar Daksh works with hospitals, clinics, and pharmacies across Bihar to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and the urgent need for strengthening healthcare infrastructure, there is immense potential to build a meaningful healthcare business while serving your community. The government is already taking steps through the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), but the demand far exceeds the supply, creating a significant opportunity for private sector participation. Popular Locations for PCD Pharma Franchise in Bihar PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Patna Cardiac diabetic PCD company in Patna PCD pharma franchise in Gaya Cardiac diabetic products in Gaya PCD pharma franchise in Muzaffarpur Diabetic cardiac PCD franchise in Muzaffarpur PCD pharma franchise in Bhagalpur Cardiac diabetic PCD company in Bhagalpur PCD pharma franchise in Darbhanga Cardiac diabetic products in Darbhanga PCD pharma franchise in Bihar Sharif Diabetic cardiac PCD franchise in Bihar Sharif PCD pharma franchise in Arrah Cardiac diabetic PCD company in Arrah PCD pharma franchise in Begusarai Cardiac diabetic products in Begusarai PCD pharma franchise in Katihar Diabetic cardiac PCD franchise in Katihar PCD pharma franchise in Munger Cardiac diabetic PCD company in Munger Conclusion The diabetes and heart disease epidemic in Bihar is not just a statistic – it is a reality affecting thousands of families. With the state reporting a prevalence of hypertension of 17.15% and diabetes of 14.45% among individuals aged 15 years and above , and rural populations showing even higher rates , the burden is already immense and growing. But there is hope. With the right medications, proper awareness, and accessible healthcare, diabetic and cardiac patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution – providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Bihar with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Assam with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Assam with Daksh Diabetes and Cardiac Care Recent data reveals that lifestyle diseases, particularly diabetes and hypertension, are rising sharply across Assam. Studies show that 8.7% of men and 5.9% of women aged 45 and above have diabetes, while a 2024 study among elderly residents in Kamrup district found a diabetes prevalence of 32.33% and hypertension prevalence of 37%. The burden extends to younger populations as well, with gestational diabetes affecting 16.67% of pregnant women in rural Assam. The Assam Health Minister has expressed concern over rising non-communicable diseases among people aged 30 and above, noting that about 15% suffer from high blood pressure and 6-7% suffer from diabetes across the state. In the tea tribe community of Nagaon district, hypertension prevalence was found to be 25.52%, while another study in Kamrup district reported a staggering hypertension prevalence of 71.7% among adults. The primary drivers include the traditional Assamese diet—rich in high glycemic index foods like rice, high saturated fat from meat and fish preparations, and sugar-rich sweets—combined with sedentary occupations, stressful urban living, declining physical activity, tobacco use, and alcohol consumption, all contributing to poor blood sugar regulation and awareness gaps in self-care practices. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Assam families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Assam 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Assam patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Assam Daksh works with hospitals, clinics, and pharmacies across Assam to ensure that quality medications reach every corner of the state. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. Assam offers immense potential for PCD pharma franchise businesses due to rising healthcare awareness, growing demand for quality medicines, and the gap in healthcare access in rural and semi-urban areas. With the increasing burden of chronic and lifestyle diseases, there is an urgent need for efficient distribution of medicines. Popular Locations for PCD Pharma Franchise in Assam PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Guwahati Cardiac diabetic PCD company in Guwahati PCD pharma franchise in Dibrugarh Cardiac diabetic products in Dibrugarh PCD pharma franchise in Silchar Diabetic cardiac PCD franchise in Silchar PCD pharma franchise in Jorhat Cardiac diabetic PCD company in Jorhat PCD pharma franchise in Nagaon Cardiac diabetic products in Nagaon PCD pharma franchise in Tinsukia Diabetic cardiac PCD franchise in Tinsukia PCD pharma franchise in Tezpur Cardiac diabetic PCD company in Tezpur PCD pharma franchise in Sivasagar Cardiac diabetic products in Sivasagar PCD pharma franchise in Golaghat Diabetic cardiac PCD franchise in Golaghat PCD pharma franchise in Lakhimpur Cardiac diabetic PCD company in Lakhimpur Conclusion The diabetes and heart disease epidemic in Assam is not just a statistic – it is a reality affecting millions of families. Many individuals are silently struggling with these conditions, often unaware of their impact on long-term health. But there is hope. With the right medications, proper awareness, and accessible healthcare, diabetic and cardiac patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution – providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Assam with Daksh Diabetes and Cardiac Care Read More »

PCD Pharma Franchise Opportunities in Andhra Pradesh with Daksh Diabetes and Cardiac Care

PCD Franchise /

PCD Pharma Franchise Opportunities in Andhra Pradesh with Daksh Diabetes and Cardiac Care Recent data from the Ministry of Health and Family Welfare reveals that lifestyle diseases, particularly diabetes and heart conditions, are reaching epidemic proportions across Andhra Pradesh. According to a survey conducted by the Medical, Health and Family Welfare Department, ten diseases account for more than 80% of the disease burden in the state, with cardiovascular diseases accounting for approximately 18-22% and diabetes mellitus accounting for 12-15% of the burden. Of the 2.15 crore adults screened across the state, 9.2% were diagnosed with hypertension and 5.1% with diabetes, with women being disproportionately affected in both cases. The prevalence is significantly higher in urban areas, with one study from the urban population of Tirupati reporting a crude diabetes prevalence of 17% (19.66% in males, 15.61% in females), increasing with age in both genders. The age and gender-adjusted prevalence of type 2 diabetes in this population was 14.47%. The solution lies in integrated diabetic and cardiac care, as diabetes is not just about blood sugar – it is a chronic metabolic condition that progressively damages blood vessels, leading to blockages, heart attacks, strokes, and nerve damage (neuropathy) that affects heart rate regulation. Adults with diabetes are two to four times more likely to develop heart failure, making early intervention critical. At Daksh Diabetic & Cardiac Care, we provide affordable, quality assured medications for both diabetes management and heart protection, including SGLT2 inhibitors like DYFOZIN (Dapagliflozin) for heart and kidney protection, statins like ROSADAC (Rosuvastatin) for cholesterol control, ARBs like DYTEI (Telmisartan) for blood pressure management, and metformin like GLYCODIP SR for blood sugar control. With WHO-GMP certified quality and competitive pricing, Daksh empowers Andhra Pradesh families to take control of their health through regular screening, medication adherence, lifestyle modifications, and early detection ensuring that every 10th person does not become a statistic but a success story of integrated care and better health outcomes. How Daksh is making a Difference in Andhra Pradesh 1. Affordable, Quality-Assured Medications Daksh Diabetic & Cardiac Care was established with a clear mission: to make quality pharmaceutical products available at affordable costs. As part of the Daksh Group of Companies which has over two decades of experience in the pharmaceutical industry the company brings credibility and trust to the diabetic and cardiac care segment. What this means for Andhra Pradesh patients: 2. Complete Cardiac Care Portfolio Daksh offers a comprehensive range of cardiac care products that address the full spectrum of heart health needs: Product Category Daksh Offerings Purpose ACE Inhibitors DORAPIL (Ramipril) Blood pressure control, heart failure treatment ARBs CARDIOVIL (Losartan), DYTEI (Telmisartan), OLMIDIP (Olmesartan) Hypertension management Beta-Blockers CARDIOVIL (Carvedilol), METODIP (Metoprolol), NEBIDAC (Nebivolol) Heart rate control, heart failure Calcium Channel Blockers DUPIN (Amlodipine), CLINITAC (Cilnidipine) Blood pressure, angina Diuretics TORDAC (Torsemide), FRUSIDIP Fluid management in heart failure Lipid Management ROSADAC (Rosuvastatin), ATRODAC (Atorvastatin) Cholesterol control 3. Complete Diabetic Care Portfolio For diabetes management, Daksh provides modern therapeutic options including: Product Category Daksh Offerings SGLT2 Inhibitors DYFOZIN (Dapagliflozin) – the modern heart-protective diabetes drug DPP-4 Inhibitors TENADAC (Teneligliptin), SITADAC (Sitagliptin), VILDADAC (Vildagliptin) Sulfonylureas GLIMIDAC (Glimepiride) Biguanides GLYCODIP SR (Metformin) Combination Therapies DYFOZIN M, GLIMIDAC MV (triple combination) 4. Focus on Preventive Care Daksh’s product portfolio includes nutritional supplements and preventive therapies that help patients maintain better health and avoid complications: 5. Supporting Healthcare Providers across Andhra Pradesh Daksh works with hospitals, clinics, and pharmacies across Andhra Pradesh to ensure that quality medications reach every corner of the state. With the state hosting 8 pharma clusters and over 400 pharmaceutical manufacturing units, Andhra Pradesh has become a fertile market for pharmaceutical distribution and PCD franchise opportunities. Through its PCD pharma franchise model, local entrepreneurs can partner with Daksh to serve their communities while building sustainable businesses. With the state’s high disease burden and expanding healthcare infrastructure, there is immense potential to build a meaningful healthcare business while serving your community. The pharmaceutical market in Andhra Pradesh is growing rapidly due to rising healthcare awareness, increasing lifestyle diseases, and better healthcare services in both cities and rural areas. Popular Locations for PCD Pharma Franchise in Andhra Pradesh PCD / Franchise Keywords Product / Therapy Keywords PCD pharma franchise in Visakhapatnam Cardiac diabetic PCD company in Visakhapatnam PCD pharma franchise in Vijayawada Cardiac diabetic products in Vijayawada PCD pharma franchise in Guntur Diabetic cardiac PCD franchise in Guntur PCD pharma franchise in Tirupati Cardiac diabetic PCD company in Tirupati PCD pharma franchise in Nellore Cardiac diabetic products in Nellore PCD pharma franchise in Kurnool Diabetic cardiac PCD franchise in Kurnool PCD pharma franchise in Rajahmundry Cardiac diabetic PCD company in Rajahmundry PCD pharma franchise in Kadapa Cardiac diabetic products in Kadapa PCD pharma franchise in Anantapur Diabetic cardiac PCD franchise in Anantapur PCD pharma franchise in Chittoor Cardiac diabetic PCD company in Chittoor Conclusion The diabetes and heart disease epidemic in Andhra Pradesh is not just a statistic – it is a reality affecting millions of families. Many individuals are silently struggling with these conditions, often unaware of their impact on long-term health. But there is hope. With the right medications, proper awareness, and accessible healthcare, diabetic and cardiac patients can live long, healthy, and fulfilling lives. Daksh Diabetic & Cardiac Care is committed to being part of this solution – providing affordable, quality-assured pharmaceutical products that align with the latest clinical guidelines. Contact Daksh Diabetic and Cardiac Contact Method Details Office Address Plot 249, Daksh House, Industrial Area Phase 2, Panchkula – 134109, Haryana, India Phone 📞 +91 93565 60523 📞 +91 78886 02869 Email enquirypurchase.daksh@gmail.com Contact us https://diabetes-cardiac.com/contact-us/

PCD Pharma Franchise Opportunities in Andhra Pradesh with Daksh Diabetes and Cardiac Care Read More »